Fasting plasma glucose level in the range of 90-99 mg/dL and the risk of the onset of type 2 diabetes: Population-based Panasonic cohort study 2

被引:6
|
作者
Munekawa, Chihiro [1 ]
Okada, Hiroshi [2 ]
Hamaguchi, Masahide [1 ]
Habu, Momoko [2 ]
Kurogi, Kazushiro [3 ]
Murata, Hiroaki [4 ]
Ito, Masato [3 ]
Fukui, Michiaki [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan
[2] Matsushita Mem Hosp, Dept Diabet & Endocrinol, Moriguchi, Osaka, Japan
[3] Panasonic Hlth Insurance Org, Dept Hlth Care Ctr, Moriguchi, Osaka, Japan
[4] Matsushita Mem Hosp, Dept Orthopaed Surg, Moriguchi, Osaka, Japan
关键词
Database research; Fasting plasma glucose level; Type; 2; diabetes; HEALTH MANAGEMENT CENTER; 5-YEAR INCIDENCE; DIAGNOSIS; THRESHOLD; HBA(1C); JAPAN;
D O I
10.1111/jdi.13692
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim/Introduction As the association between a fasting glucose concentration of 90-99 mg/dL and the onset of type 2 diabetes is still controversial, we aimed to assess it in 37,148 Japanese individuals with a normal plasma glucose concentration. Materials and Methods This long-term retrospective cohort study included individuals having a medical checkup at Panasonic Corporation from 2008 to 2018. In total, 1,028 participants developed type 2 diabetes. Results Cox regression analyses revealed that the risk for the onset of diabetes increased by 9.0% per 1 mg/dL increase in fasting plasma glucose concentration in subjects with the concentration ranging from 90 to 99 mg/dL. Compared with individuals with a fasting glucose concentration of <= 89 mg/dL, the adjusted hazard ratios for developing diabetes were 1.53 (95% CI; 1.22-1.91), 1.76 (95% CI; 1.41-2.18), 1.89 (95% CI; 1.52-2.35), 3.17 (95% CI; 2.61-3.84), and 3.41 (95% CI; 2.79-4.15) at fasting plasma glucose concentrations of 90-91, 92-93, 94-95, 96-97, and 98-99 mg/dL, respectively. In populations with obesity, the adjusted hazards ratios for developing diabetes were 1.56 (95% CI; 1.15-2.09), 1.82 (95% CI; 1.37-2.40), 2.05 (95% CI; 1.55-2.69), 3.53 (95% CI; 2.79-4.46), and 3.28 (95% CI; 2.53-4.22) at fasting plasma glucose concentrations of 90-91, 92-93, 94-95, 96-97, and 98-99 mg/dL, respectively. Conclusions This study demonstrates that the risk of type 2 diabetes among subjects having a fasting plasma glucose concentration of 90-99 mg/dL, is progressively higher with an increasing level of fasting plasma glucose concentration in a Japanese people.
引用
收藏
页码:453 / 459
页数:7
相关论文
共 50 条
  • [41] Frailty and risk of microvascular complications in patients with type 2 diabetes: a population-based cohort study
    Wu, Yuanjue
    Xiong, Ting
    Tan, Xiao
    Chen, Liangkai
    BMC MEDICINE, 2022, 20 (01)
  • [42] Dipstick proteinuria and risk of type 2 diabetes mellitus: a nationwide population-based cohort study
    Jeon, Jimin
    Kim, Jinkwon
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [43] Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study
    D. Martinez-Laguna
    C. Tebe
    M. K. Javaid
    X. Nogues
    N. K. Arden
    C. Cooper
    A. Diez-Perez
    D. Prieto-Alhambra
    Osteoporosis International, 2015, 26 : 827 - 833
  • [44] Type 2 diabetes mellitus and colorectal cancer risk: A population-based, historical cohort study
    Limburg, P
    Vierkant, R
    Fredericksen, Z
    Leibson, C
    Melton, LJ
    Rizza, R
    Gupta, A
    Ahlquist, D
    Sellers, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S121 - S121
  • [45] Type 2 diabetes, obesity, and risk of amyotrophic lateral sclerosis: A population-based cohort study
    Skajaa, Nils
    Riahi, Emil Bjerregaard
    Szepligeti, Szimonetta Komjathine
    Horvath-Puho, Erzsebet
    Sorensen, Trine Toft
    Henderson, Victor W.
    Sorensen, Henrik Toft
    BRAIN AND BEHAVIOR, 2023, 13 (06):
  • [46] Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study
    Alkabbani, Wajd
    Maxwell, Colleen J. J.
    Marrie, Ruth Ann
    Tyas, Suzanne L. L.
    Lega, Iliana C. C.
    Gamble, John-Michael
    DIABETES CARE, 2023, 46 (08) : 1492 - 1500
  • [47] Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study
    Martinez-Laguna, D.
    Tebe, C.
    Javaid, M. K.
    Nogues, X.
    Arden, N. K.
    Cooper, C.
    Diez-Perez, A.
    Prieto-Alhambra, D.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (02) : 827 - 833
  • [48] Dipstick proteinuria and risk of type 2 diabetes mellitus: a nationwide population-based cohort study
    Jimin Jeon
    Jinkwon Kim
    Journal of Translational Medicine, 19
  • [49] Sodium-glucose co-transporter-2 inhibitors reduce the risk of new-onset stroke in patients with type 2 diabetes: A population-based cohort study
    Lin, Tsung-Kun
    Chen, Yong-Hsin
    Huang, Jing-Yang
    Liao, Pei-Lun
    Chen, Mei-Chun
    Pan, Lung-Fa
    Jong, Gwo-Ping
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [50] Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
    Eroglu, Talip E.
    Coronel, Ruben
    Souverein, Patrick C.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (04) : 289 - 295